COHN vs GSK · P/E 2.5, rev $127.4M vs P/E 13, $103.31B cap
Cohen & Company Inc (COHN) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Cohen & Company Inc (COHN) is a capital markets company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported COHN revenue for 2026-06-30 was $127.4M. Net income was $5.1M. COHN currently screens at market cap $28.8M and trailing P/E 2.5.
GSK does not have a complete income-statement cache yet.
COHN currently screens at market cap $28.8M and trailing P/E 2.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the COHN and GSK stock pages for the full models.
Not investment advice.